Biochemical and pharmacological characterization of isatin and its derivatives: From structure to activity

Pharmacological Reports

Volumn 65, Issue 2, 2013, Pages 313-335

  Pakravan, Parvaneh ^a   Kashanian, Soheila ^b   Khodaei, Mohammad M ^b   Harding, Frances J ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b RAZI UNIVERSITY   (Iran)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Anticancer; Anticonvulsant; Antimicrobial; Antioxidant; Derivatives; DNA and HSA binding; Isatin

Indexed keywords

2 INDOLONE IMINO DERIVATIVE; CARBAMAZEPINE; CONVOLUTAMYDINE A; CPC 1; DIOXIBRASSININ; HYDRAZONE DERIVATIVE; INDOLE DERIVATIVE; ISATIN; ISATIN 2 OXIME; ISATIN 3 OXIME; ISATIN 3 THIOSEMICARBAZONE DERIVATIVE; ISATIN DERIVATIVE; MAREMYCLIN A; MAREMYCLIN B; PHENYTOIN; SEMAXANIB; SM 130686; SPIROBRASSININ; SU 9516; SUNITINIB; THIOSEMICARBAZONE; TMC 95A; UNCLASSIFIED DRUG; VALPROIC ACID;

ACYLATION; ALKYLATION; ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; CATALYSIS; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; HALOGENATION; HUMAN; HYDROGEN BOND; IC 50; KLEBSIELLA PNEUMONIAE; MANNICH REACTION; MICHAEL ADDITION; MICROWAVE IRRADIATION; MINIMUM INHIBITORY CONCENTRATION; NEUROPROTECTION; NONHUMAN; POLYMERIZATION; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 84879360881     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71007-7     Document Type: Review

References (86)

1. Abele E, Abele R, Dzenitis O, Lukevics E: Indole and isatin oximes: synthesis, reactions, and biological activity. Chem Heterocycl Compd, 2003, 39, 3-35.
2. Adibi H, Khodaei MM, Pakravan P, Abiri R: Synthesis, characterization, and in vitro antimicrobial evaluation of hydrazone and bishydrazone derivatives of isatin. Pharm Chem J, 2010, 44, 219-227.
3. Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M et al.: New isatin derivatives with antioxidant activity. Eur J Med Chem, 2010, 45, 1374-1378.
4. Bhrigu B, Pathak D, Siddiqui N, Alam MS, Ahsan W: Search for biological active isatins: a short review. Int J Pharm Sci Drug Res, 2010, 2, 229-235.
5. Calvery HO, Noller CR, Adams R: Arsonophenylcinchoninic acid (arsonocinchophen) and derivatives II. J Am Chem Soc, 1925, 47, 3058-3060.
6. Cerchiaro G, Ferreira AMDC: Oxindoles and copper complexes with oxindole-derivatives as potential pharmacological agents. J Braz Chem Soc, 2006, 17, 1473-1485.
7. Chaluvaraju KC, Zaranappa: Synthesis and biological evaluation of some isatin derivatives for antimicrobial properties. Res J Pharm Biol Chem Sci, 2011, 2, 541-546.
8. Chen G, Wang Y, Hao X, Mu S, Sun Q: Simple isatin derivatives as free radical scavengers: synthesis, biological evaluation and structure-Activity relationship. Chem Cent J, 2011, 5, 1-5.
9. Chibale K: Economic drug discovery and rational medicinal chemistry for tropical diseases. Pure Appl Chem, 2005, 77, 1957-1964.
10. Da Silva JFM, Garden SJ, Pinto AC: The chemistry of isatins: a review from 1975 to 1999, J Braz Chem Soc, 2001, 12, 273-324.
11. da Silveira VC, Caramori GF, Abbott MP, Gonçalves MB, Petrilli HM, Ferreira AMDC: Oxindole-Schiff base copper(II) complexes interactions with human serum albumin: spectroscopic, oxidative damage, and computational studies. J Inorg Biochem, 2009, 103, 1331-1341.
12. Dalton SR, Glazier S, Leung B, Win S, Megatulski C, Burgmayer SJN: DNA binding by Ru(II)-bis(bipyridine)-pteridinyl complexes. J Biol Inorg Chem, 2008, 13, 1133-1148.
13. De Souza SPL, Da Silva JFM, De Mattos MCS: SiO2 mediated reaction of isatin with N-halosaccharins: A regiospecific preparation of 5-haloisatins. Heterocycl Commun, 2003, 9, 31-34.
14. Elinson MN, Merkulova VM, Ilovaisky AI, Barba F, Batanero B: Electrocatalytic tandem Knoevenagel-Michael addition of barbituric acids to isatins: Facile and efficient way to substituted 5,5'-(2-oxo-2,3-dihydro- 1Hindole-3,3-diyl)bis(pyrimidine-2,4,6-(1H,3H,5H)-trione) scaffold. Electrochim Acta, 2011, 56, 8219-8223.
15. Ezzati Nazhad Dolatabadi J, Kashanian S: A review on DNA interaction with synthetic phenolic food additives. Food Res Int, 2010, 43, 1223-1230.
16. Filomeni G, Cerchiaro G, Ferreira AMDC, De Martino A, Pedersen JZ, Rotilio G, Ciriolo MR: Pro-Apoptotic activity of novel isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage. J Biol Chem, 2007, 282, 12010-12021.
17. George S, Parameswaran MK, Chakraborty AR, Ravi TK: Synthesis and evaluation of the biological activities of some 3-{[5-(6-methyl-4-Aryl-2-oxo-1, 2,3,4-tetrahydropyrimidin-5-yl)-1,3,4-oxadiazol-2-yl]-imino}-1, 3-dihydro-2H-indol-2-one derivatives. Acta Pharm, 2008, 58, 119-129.
18. Gudipati R, Anreddy RNR, Manda S: Synthesis, characterization and anticancer activity of certain 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl) phenylimino}indolin-2-one derivatives. Saudi Pharm J, 2011, 19, 153-158.
19. Guo X, Huang H, Yang L, Hu W: Trapping of oxonium ylide with isatins: efficient and stereoselective construction of adjacent quaternary carbon centers. Org Lett, 2007, 9, 4721-4723.
20. Gurkok G, Altanlar N, Suzen S: Investigation of antimicrobial activities of Indole-3-Aldehyde hydrazide/hydrazone derivatives. Chemotherapy, 2009, 55, 15-19.
21. Hall MD, Salam NK, Hellawell JL, Fales HM, Kensler CB, Ludwig JA, Szakács G et al.: Synthesis, activity, and pharmacophore development for isatin-b-thiosemicarbazones with selective activity toward multidrug-resistant cells. J Med Chem, 2009, 52, 3191-3204.
22. Jarrahpour A, Khalili D, Clercq ED, Salmi C, Brunel J.M: Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives. Molecules, 2007, 12, 1720-1730.
23. Kang IJ, Wang LW, Hsu TA, Yueh A, Lee CC, Lee YC, Lee CY et al.: Isatin-b-thiosemicarbazones as potent herpes simplex virus inhibitors. Bioorg Med Chem Lett, 2011, 21, 1948-1952.
24. Kara LV, Locke JM, Ranson M, Pyne SG, Bremner JB: In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorg Med Chem, 2007, 15, 931-938.
25. Karki SS, Thota S, Darj SY, Balzarinib J, De Clercq E: Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds. Bioorg Med Chem, 2007, 15, 6632-6641.
26. Karpenko AS, Shibinskaya MO, Zholobak NM, Olevinskaya ZM, Lyakhov SA, Litvinova LA, Spivak MY, Andronati SA: Synthesis, DNA-binding, and interferon-inducing properties of isatin and benzoisatin hydrazones. Pharm Chem J, 2006, 40, 595-602.
27. Kashanian S, Askari S, Ahmadi F, Omidfar K, Ghobadi S, Tarighat FA: In vitro study of DNA interaction with clodinafop-propargyl herbicide. DNA Cell Biol, 2008, 27, 581-586.
28. Kashanian S, Ezzati Nazhad Dolatabadi J: DNA binding studies of 2-tert-butylhydroquinone (TBHQ) food additive. Food Chem, 2009, 116, 743-747.
29. Kashanian S, Ezzati Nazhad Dolatabadi J: In vitro studies on calf thymus DNA interaction and 2-tertbutyl-4-methylphenol food additive. Eur. Food Res Technol, 2010, 230, 821-825.
30. Kashanian S, Ezzati Nazhad Dolatabadi J: In vitro study of calf thymus DNA interaction with butylated hydroxyanisole. DNA Cell Biol, 2009, 28, 535-540.
31. Kashanian S, Khodaei MM, Pakravan P, Adibi H: Molecular aspects on the interaction of isatin-3-isonicotinylhydrazone to deoxyribonucleic acid: model for intercalative drug-DNA binding. Mol Biol Rep, 2011, 39, 3853-3861.
32. Kashanian S, Khodaei MM, Pakravan P: Spectroscopic studies on the interaction of isatin with calf thymus DNA. DNA Cell Biol, 2010, 29, 639-646.
33. Khorshidi A, Tabatabaeian K: An ultrasound-promoted green approach for the synthesis of 3-(indol-3-yl)-3-hydroxyindolin-2-ones catalyzed by Fe(III). J Serb Chem Soc, 2011, 76, 1347-1353.
34. Konstantinoviæ SS, Cakiæ VS: Pharmacological characteristics of some 3-salicylidenehydrazono-2-indolinone coordination compounds. Med Chem Res, 2010, 19, 771-781.
35. Konstantinoviæ SS, Kapor A, Radovanoviæ BC, Deak A: Synthesis, X-ray and antimicrobial activity of isatin-3-phenylhydrazone. Chem Ind Chem Eng Q, 2008, 14, 27-34.
36. Kulkarni AD, Patil SA, Badami PS: Electrochemical properties of some transition metal complexes: synthesis, characterization and in-vitro antimicrobial studies of Co(II), Ni(II), Cu(II), Mn(II) and Fe(III) complexes. Int J Electrochem Sci, 2009, 4, 717-729.
37. Lakshmi B, Shivananda KN, Prakash GA, Rama KRK, Mahendra KN: Synthesis of Co(II), Ni(II) and Cu(II) complexes from Schiff base ligand and reactivity studies with thermosetting epoxy resin. Bull Korean Chem Soc, 2011, 32, 1613-1619.
38. Li TR, Yang ZY, Wang BD, Qin DD: Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth(III) complexes with naringenin-2-hydroxy benzoyl hydrazone ligand. Eur J Med Chem, 2007, 43, 1688-1695.
39. Li Yh, Wang Bd, Yang Zy: Infrared and DNA-binding on ultraviolet and fluorescence spectra of new copper and zinc complexes with a naringenin Schiff-base ligand. Spectrochim Acta Part A, 2007, 67, 395-401.
40. Lindwell HG, Bandes J, Weinberg I: Preparation of certain brominated cincophens. J Am Chem Soc, 1931, 53, 317-319.
41. Liu ZQ, Jiang M, Li YT, Wu ZY, Yang JX: Onedimensional copper(II) polymer with bridging m-transoxamidate and thiocyanate ligands: synthesis, crystal structure and DNA binding studies. Inorg Chim Acta, 2009, 362, 1253-1259.
42. Malhotra S, Balwani S, Dhawan A, Singh BK, Kumar S, Thimmulappa R, Biswal S et al.: Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells. Med Chem Commun, 2011, 2, 743-751.
43. Mendonça GF, Magalhães RR, De Mattos MCS, Esteves PM: Trichloroisocyanuric acid in H2SO4: An efficient superelectrophilic reagent for chlorination of isatin and benzene derivatives. J Braz Chem Soc, 2005, 16, 695-698.
44. Meshram HM, Ramesh Palakuri, Kumar AS, Swetha A: An efficient and environmentally friendly DABCO catalyzed Henry reaction of isatins. Tetrahedron Lett, 2011, 52, 5862-5864.
45. Mesropyan EG, Avetisyan AA: New isatin derivatives. Russ J Org Chem, 2009, 45, 1583-1593.
46. Mondal P, Jana S, Kanthal LK: Synthesis of novel mercapto-pyrimidine and amino-pyrimidine derivatives of indoline-2-one as potential antioxidant & antibacterial agents. T Ph Res, 2010, 3, 17-26.
47. Mondal P, Jana S, Mahanti B, Kanthal L.K, Banerjee M: Synthesis & evaluation of some novel pyrazoline derivatives of indole-2,3-dione as a potential antioxidant & antibacterial agents. Int J Pharm Sci Tech, 2009, 3, 8-11.
48. Naik N, Vijay Kumar H, Vidyashree PB: Synthesis and evaluation of antioxidant potential of novel isatin analogues. J Pharm Res, 2011, 4, 2686-2689.
49. Nathani BR, Pandya KS, Jeni MM, Patel MR: Synthesis and antimicrobial activity of some new isatins derivatives. Der Pharma Chemica, 2011, 3, 367-372.
50. Pal M, Sharma NK, Priyanka P, Jha KK: Synthetic and biological multiplicity of isatin: a review. J Adv Sci Res, 2011, 2, 35-44.
51. Pandeya SN, Smitha S, Jyoti M, Sridhar SK: Biological activities of isatin and its derivatives. Acta Pharm, 2005, 55, 27-46.
52. Pandeya SN, Sriram D, Nath G, De Clercq E: Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-Amino-2-methylmercapto quinazolin-4(3H) -one. Pharm Acta Helv, 1999, 74, 11-17.
53. Pandya P, Islam MM, Kumar GS, Jayaram B, Kumar S: DNA minor groove binding of small molecules: experimental and computational evidence. J Chem Sci, 2010, 122, 247-257.
54. Patela A, Baria S, Talele G, Patel J, Sarangapanib M: Synthesis and antimicrobial activity of some new isatin derivatives. Iran J Pharm Res, 2006, 4, 249-254.
55. Pawar Y, Sonawane A, Nagle P, Mahulikar P, More D: Synthesis of 1,4-benzothiazine compound containing isatin moieties as antimicrobial agent. Int J Curr Pharm Res, 2011, 3, 47-51.
56. Popp FD: The chemistry of isatin. Adv Hetercycl Chem, 1975, 18, 1-59.
57. Prakash CR, Raja S, Panneer Selvam T, Saravanan G, Karthick V, Dinesh Kumar P: Synthesis and antimicrobial activities of some novel Schiff bases of 5-substituted isatin derivatives. RASÂYAN J Chem, 2009, 2, 960-968.
58. Raj M, Veerasamy N, Singh VK: Highly enantioselective synthesis of 3-cycloalkanone-3-hydroxy-2-oxindoles, potential anticonvulsants. Tetrahedron Lett, 2010, 51, 2157-2159.
59. Rajendran A, Nair BU: Unprecedented dual binding behaviour of acridine group of dye: A combined experimental and theoretical investigation for the development of anticancer chemotherapeutic agents. Biochim Biophys Acta, 2006, 1760, 1794-1801.
60. Ramachandran S: Synthesis and antimicrobial evaluation of some novel schiff and mannich bases of isatin derivatives. Int J Res Pharm Chem, 2011, 1, 289-294.
61. Raman N, Sobha S: Synthesis, characterization, DNA interaction and antimicrobial screening of isatin-based polypyridyl mixed-ligand Cu(II) and Zn(II) complexes. J Serb Chem Soc, 2010, 75, 773-788.
62. Ranjit K, Rao GK, Pai PNS: Synthesis and biological evaluation of N1-[(3z)-5-substituted-2-oxo-1,2-dihydro-3H-indol-3-ylidene]-5H-dibenzo[b,f] azepine-5-carbohydrazides. Int J Biol Chem, 2010, 4, 19-26.
63. Ravichandran V, Mohan S, Suresh Kumar K: Synthesis and antimicrobial activity of Mannich bases of isatin and its derivatives with 2-[(2,6-dichlorophenyl)amino]phenylacetic acid. Arkivoc, 2007, xiv, 51-57.
64. Rodríguez-Argüelles MC, Cao R, García-Deibe AM, Pelizzi C, Sanmartín-Matalobos J, Zani F: Antibacterial and antifungal activity of metal(II) complexes of acylhydrazones of 3-isatin and 3-(N-methyl)isatin. Polyhedron, 2009, 28, 2187-2195.
65. Roskoski Jr. R: Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun, 2007, 356, 323-328.
66. Sammaiah G, Brahmeshwari G, Sarangapani M: Synthesis and biological activity of 2-Aminobezoic acid (2-oxo-1, 2 dihydro-indol-3-ylidene)-hydrazides. J Adv Pharm Sci, 2011, 1, 47-52.
67. Schütz E, Von Ahsen N: Influencing factors of dsDNA dye (high-resolution) melting curves and improved genotype call based on thermodynamic considerations. Anal Biochem, 2009, 385, 143-152.
68. Shahabadi N, Kashanian S, Darabi F: DNA binding and DNA cleavage studies of a water soluble cobalt(II) complex containing dinitrogen Schiff base ligand: The effect of metal on the mode of binding. Eur J Med Chem, 2010, 45, 4239-4245.
69. Shahabadi N, Kashanian S, Darabi F: In vitro study of DNA interaction with a water-soluble dinitrogen Schiff base. DNA Cell Biol, 2009, 28, 589-596.
70. Sharma K, Biyala MK, Swami M, Fahmi N, Singh RV: Coordination chemistry of palladium(II) and platinum(II) complexes with bioactive Schiff bases: synthetic, spectral, and biocidal aspects. Russ J Coord Chem, 2009, 35, 142-148.
71. Shmidt MS, Reverdito AM, Kremenchuzky L, Perillo IA, Blanco MM: Simple and efficient microwave assisted N-Alkylation of isatin. Molecules, 2008, 13, 831-840.
72. Siddiqui N, Akhtar MJ, Ali R, Azad B, Andalip: An updated review: emerging anticonvulsants. Int J Pharm Biol Arch, 2010, 1, 404-415.
73. Siddiqui N, Alam MS, Stables JP: Synthesis and anticonvulsant properties of 1-(amino-N-Arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives. Eur J Med Chem, 2011, 46, 2236-2242.
74. Silva BV, Esteves PM, Pinto AC: Chlorination of isatins with trichloroisocyanuric acid. J Braz Chem Soc, 2011, 22, 257-263.
75. Smitha S, Pandeya SN, Stables JP, Ganapathy S: Anticonvulsant and sedative-hypnotic activities of N-Acetyl/methyl isatin derivatives. Sci Pharm, 2008, 76, 621-636.
76. Solomon VR, Hu C, Lee H: Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity. Bioorg Med Chem 2009, 17, 7585-7592.
77. Song G, Yan Q, He Y: Studies on interaction of norfloxacin, Cu2+, and DNA by spectral methods. J Fluoresc, 2005, 15, 673-678.
78. Sridhar SK, Pandeya SN, Stables JP, Ramesh A: Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Pharm Sci, 2002, 16, 129-132.
79. Sriram D, Bal TR, Yogeeswari P: Synthesis, antiviral and antibacterial activities of isatin mannich bases. Med Chem Res, 2005, 14, 211-228.
80. Srivastava A, Pandeya SN: "Indole" a versatile nucleus in the pharmaceutical field. Int J Curr Pharm Rev Res, 2011, 1, 1-17.
81. Sun L, Liang C, Shirazian S, Zhou Y, Miller T, Cui J, Fukuda JY et al.: Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1Hpyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet derived growth factor receptor tyrosine kinase. J Med Chem, 2003, 46, 1116-1119.
82. Verma M, Pandeya SN, Singh KN, Stables JP: Anticonvulsant activity of Schiff bases of isatin derivatives. Acta Pharm, 2004, 54, 49-56.
83. Vine KL, Locke JM, Ranson M, Pyne SG, Bremner JB: An investigation into the cytotoxicity and mode of action of some novel N-Alkyl-substituted isatins. J Med Chem, 2007, 50, 5109-5117.
84. Viswambharan B, Selvakumar K, Madhavan S, Shanmugam P: Pyridine core activation via 1,5-electrocyclization of vinyl pyridinium ylides generated from bromo isomerized Morita-Baylis-Hillman adduct of isatin and pyridine: synthesis of 3-spirodihydroindolizine oxindoles. Org Lett, 2010, 12, 2108-2111.
85. Yu F, Yan S, Hu L, Wang Y, Lin J: Cascade reaction of isatins with heterocyclic ketene aminals: Synthesis of imidazopyrroloquinoline derivatives. Org Lett, 2011, 13, 4782-4785.
86. Zhang Y, Li ZJ, Xu H.S, Zhang Y, Wang W: Organocatalytic asymmetric Henry reaction of isatins: Highly enantioselective synthesis of 3-hydroxy-2- oxindoles. RSC Adv, 2011, 1, 389-392.